首页 › 基金 › Octagon Capital Advisors LP › COGT
Octagon Capital Advisors LP 对 COGT 的持仓历史
COGENT BIOSCIENCES INC · 医疗保健
Octagon Capital Advisors LP 在 Q3 2026 的 13F 申报中披露持有 COGT(COGENT BIOSCIENCES INC)2,350,000 股,市值约 US$75.2M,约占其申报组合的 10.02%,在其申报持仓中市值排名第 4 位。 Octagon Capital Advisors LP 最近 9 个申报季度中有 9 个季度披露了 COGT 持仓,最早可追溯至 Q3 2024。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Octagon Capital Advisors LP 对 COGT 的持仓演变
Octagon Capital Advisors LP 于 Q3 2024 首次披露 COGT 持仓:1,305,000 股(约 US$14.1M)。 该持仓在 Q2 2026 达到峰值 2,350,000 股,市值约 US$90.9M。 在 9 次申报中,Octagon Capital Advisors LP 2 次增持、1 次减持、5 次保持不变。 最近一期申报(Q3 2026)显示持股 2,350,000 股、市值约 US$75.2M。 持仓曾出现大幅变动:Q4 2024 增持约 112% (随后一个季度股价下跌 23%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2024 | 1.30M | $14.09M | 新进 |
| Q4 2024 | 2.76M | $21.55M | 增持 |
| Q1 2025 | 2.76M | $16.55M | 持有 |
| Q2 2025 | 2.76M | $19.84M | 持有 |
| Q3 2025 | 2.87M | $41.27M | 增持 |
| Q4 2025 | 2.35M | $83.47M | 减持 |
| Q1 2026 | 2.35M | $90.45M | 持有 |
| Q2 2026 | 2.35M | $90.94M | 持有 |
| Q3 2026 | 2.35M | $75.25M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 COGT 与 13F 数据
COGT(COGENT BIOSCIENCES INC)属于医疗保健行业。我们追踪的基金中还有 50 只申报持有 COGT,申报仓位最大的包括:DEERFIELD MANAGEMENT COMPANY, L.P. (US$190.7M), Fairmount Funds Management LLC (US$176.2M), Kynam Capital Management, LP (US$121.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 COGT 的基金
- DEERFIELD MANAGEMENT COMPANY, L.P. 5.96M 股 · $190.74M · Q3 2026
- Fairmount Funds Management LLC 5.50M 股 · $176.22M · Q3 2026
- Kynam Capital Management, LP 3.79M 股 · $121.43M · Q3 2026
- TCG Crossover Management, LLC 2.50M 股 · $80.05M · Q3 2026
- Deep Track Capital, LP 2.50M 股 · $80.05M · Q3 2026
- RTW INVESTMENTS, LP 2.31M 股 · $73.93M · Q3 2026
- ORBIMED ADVISORS LLC 2.00M 股 · $64.16M · Q3 2026
- Venrock Adviser, LLC 1.64M 股 · $52.58M · Q3 2026
- EMERALD ADVISERS, LLC 1.61M 股 · $51.67M · Q3 2026
- Siren, L.L.C. 1.61M 股 · $51.53M · Q3 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 1.57M 股 · $50.42M · Q3 2026
- Commodore Capital LP 1.26M 股 · $40.51M · Q3 2026
更多关于 Octagon Capital Advisors LP
常见问题
How long has Octagon Capital Advisors LP held COGT?
Octagon Capital Advisors LP has disclosed COGT holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is Octagon Capital Advisors LP's current position in COGT?
As of Q3 2026, Octagon Capital Advisors LP holds 2.35M shares of COGT (COGENT BIOSCIENCES INC), valued at $75.25M, representing 10.02% of its reported portfolio and ranking #4.
Has Octagon Capital Advisors LP been buying or selling COGT?
In the latest 13F filing (Q3 2026), Octagon Capital Advisors LP held unchanged its position in COGT. The position peaked in Q2 2026 at 2.35M shares.
Which other funds hold COGT?
Other major institutional holders of COGT include DEERFIELD MANAGEMENT COMPANY, L.P., Fairmount Funds Management LLC, Kynam Capital Management, LP, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.